Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
In the last decade, a plethora of immunotherapeutic strategies have been designed to modulate the tumor immune microenvironment. In particular, immune checkpoint (IC) blockade therapies present the most promising advances made in cancer treatment in recent years. In non-small cell lung cancer (NSCLC...
Saved in:
| Main Authors: | Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, Jérôme Galon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2243169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Principles of risk assessment in colon cancer: immunity is key
by: Assia Hijazi, et al.
Published: (2024-12-01) -
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
by: Fulong Wang, et al.
Published: (2023-12-01) -
Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy
by: Xiangyu Yin, et al.
Published: (2024-11-01) -
Enhancing cancer care with improved checkpoint inhibitors
by: Vickram A S, et al.
Published: (2024-10-01) -
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
by: Luigi Liguori, et al.
Published: (2024-11-01)